Nagelhout Pharmacology Exam 1 Review Questions
With Correct Answers
Pharmacology |- |CORRECT |ANSWER✔✔-the |study |of |the |effect |of |chemicals |on |living |tissue
Pharmacokinetics |- |CORRECT |ANSWER✔✔-the |study |of |the |absorption, |distribution, |
metabolism |and |excretion |of |drugs
Pharmaceutics |- |CORRECT |ANSWER✔✔-the |formulation |and |preparation |of |drugs
pharmacoeconomics |- |CORRECT |ANSWER✔✔-the |study |of |the |economic |impact |of |drugs
toxicology |- |CORRECT |ANSWER✔✔-the |study |of |the |harmful |effects |of |chemicals
pharmacognosy |- |CORRECT |ANSWER✔✔-the |study |of |the |medicinal |uses |of |naturally |
occurring |compounds
pharmacy |- |CORRECT |ANSWER✔✔-the |preparation |and |dispensing |of |drugs
pharmacogenetics |- |CORRECT |ANSWER✔✔-genetic |influences |by |and |on |drugs
pharmacodynamics |- |CORRECT |ANSWER✔✔-physiological |and |biochemical |mechanism |of |
action |of |drugs
(e.g. |receptor |theory)
pharmacogenomics |- |CORRECT |ANSWER✔✔-identifies |discrete |genetic |differences |among |
individuals |that |play |a |critical |role |in |drug |response
,pharmacoepidemiology |- |CORRECT |ANSWER✔✔-is |the |study |of |the |use |and |effects |of |drugs |
on |large |groups |of |people
ED50 |- |CORRECT |ANSWER✔✔-Effective |dose |in |50% |of |the |population
TD50 |- |CORRECT |ANSWER✔✔-Toxic |Dose |in |50% |of |the |population
LD50 |- |CORRECT |ANSWER✔✔-Lethal |Dose |in |50% |of |the |population
Therapeutic |index |- |CORRECT |ANSWER✔✔-LD50/ED50
Therapeutic |window |- |CORRECT |ANSWER✔✔-TD50/ED50
Two |types |of |ligands |- |CORRECT |ANSWER✔✔-Agonist |or |Antagonist
Reversible |binding |of |ligands |is |called |- |CORRECT |ANSWER✔✔-competitive
non-reversible |binding |of |ligands |is |called |- |CORRECT |ANSWER✔✔-noncompetitive
5 |types |of |chemical |bonds |in |order |of |increasing |strength |- |CORRECT |ANSWER✔✔-van |der |
waals, |hydrophobic, |hydrogen, |ionic, |covalent
5 |types |of |chemical |bonds |in |order |of |decreasing |strength |- |CORRECT |ANSWER✔✔-covalent, |
ionic, |hydrogen, |hydrophobic, |van |der |waals
Occupation |of |receptors |by |ligands |is |governed |by: |- |CORRECT |ANSWER✔✔-affinity
, Activation |of |receptors |by |ligands |is |governed |by: |- |CORRECT |ANSWER✔✔-efficacy
A |dose |response |curve |can |show: |- |CORRECT |ANSWER✔✔-Affinity |(potency), |Efficacy, |
Variability, |Slope
Up |regulation |- |CORRECT |ANSWER✔✔-an |increase |in |receptor |proteins |as |a |response |to |
chronic |blockade
Down |regulation |- |CORRECT |ANSWER✔✔-Desensitization |(refractoriness) |following |continued |
stimulation |(agonists). |Chronic |beta |stimulant |use |for |asthma |resulting |in |increased |dose |
necessary |is |an |example
Drug |Interaction |- |CORRECT |ANSWER✔✔-Alteration |in |the |therapeutic |action |of |a |drug |by |
concurrent |administration |of |other |exogenous |chemicals
1+1 |= |2 |- |CORRECT |ANSWER✔✔-Addition; |The |combined |effect |of |two |drugs |acting |via |the |
same |mechanism |is |equal |to |that |expected |by |simple |addition |of |their |individual |actions
Ex) |midazolam |+ |diazepam
1+1=3 |- |CORRECT |ANSWER✔✔-synergism; |The |combined |effect |of |two |drugs |is |greater |than |
the |sum |of |their |individuals |effects
Ex) |Midazolam |+ |Propofol
1+0=3 |- |CORRECT |ANSWER✔✔-potentiation; |The |enhancement |of |the |action |of |one |drug |by |a
|second |that |has |no |detectable |action |of |its |own. |
Ex) |Penicillin |+ |probenacid
With Correct Answers
Pharmacology |- |CORRECT |ANSWER✔✔-the |study |of |the |effect |of |chemicals |on |living |tissue
Pharmacokinetics |- |CORRECT |ANSWER✔✔-the |study |of |the |absorption, |distribution, |
metabolism |and |excretion |of |drugs
Pharmaceutics |- |CORRECT |ANSWER✔✔-the |formulation |and |preparation |of |drugs
pharmacoeconomics |- |CORRECT |ANSWER✔✔-the |study |of |the |economic |impact |of |drugs
toxicology |- |CORRECT |ANSWER✔✔-the |study |of |the |harmful |effects |of |chemicals
pharmacognosy |- |CORRECT |ANSWER✔✔-the |study |of |the |medicinal |uses |of |naturally |
occurring |compounds
pharmacy |- |CORRECT |ANSWER✔✔-the |preparation |and |dispensing |of |drugs
pharmacogenetics |- |CORRECT |ANSWER✔✔-genetic |influences |by |and |on |drugs
pharmacodynamics |- |CORRECT |ANSWER✔✔-physiological |and |biochemical |mechanism |of |
action |of |drugs
(e.g. |receptor |theory)
pharmacogenomics |- |CORRECT |ANSWER✔✔-identifies |discrete |genetic |differences |among |
individuals |that |play |a |critical |role |in |drug |response
,pharmacoepidemiology |- |CORRECT |ANSWER✔✔-is |the |study |of |the |use |and |effects |of |drugs |
on |large |groups |of |people
ED50 |- |CORRECT |ANSWER✔✔-Effective |dose |in |50% |of |the |population
TD50 |- |CORRECT |ANSWER✔✔-Toxic |Dose |in |50% |of |the |population
LD50 |- |CORRECT |ANSWER✔✔-Lethal |Dose |in |50% |of |the |population
Therapeutic |index |- |CORRECT |ANSWER✔✔-LD50/ED50
Therapeutic |window |- |CORRECT |ANSWER✔✔-TD50/ED50
Two |types |of |ligands |- |CORRECT |ANSWER✔✔-Agonist |or |Antagonist
Reversible |binding |of |ligands |is |called |- |CORRECT |ANSWER✔✔-competitive
non-reversible |binding |of |ligands |is |called |- |CORRECT |ANSWER✔✔-noncompetitive
5 |types |of |chemical |bonds |in |order |of |increasing |strength |- |CORRECT |ANSWER✔✔-van |der |
waals, |hydrophobic, |hydrogen, |ionic, |covalent
5 |types |of |chemical |bonds |in |order |of |decreasing |strength |- |CORRECT |ANSWER✔✔-covalent, |
ionic, |hydrogen, |hydrophobic, |van |der |waals
Occupation |of |receptors |by |ligands |is |governed |by: |- |CORRECT |ANSWER✔✔-affinity
, Activation |of |receptors |by |ligands |is |governed |by: |- |CORRECT |ANSWER✔✔-efficacy
A |dose |response |curve |can |show: |- |CORRECT |ANSWER✔✔-Affinity |(potency), |Efficacy, |
Variability, |Slope
Up |regulation |- |CORRECT |ANSWER✔✔-an |increase |in |receptor |proteins |as |a |response |to |
chronic |blockade
Down |regulation |- |CORRECT |ANSWER✔✔-Desensitization |(refractoriness) |following |continued |
stimulation |(agonists). |Chronic |beta |stimulant |use |for |asthma |resulting |in |increased |dose |
necessary |is |an |example
Drug |Interaction |- |CORRECT |ANSWER✔✔-Alteration |in |the |therapeutic |action |of |a |drug |by |
concurrent |administration |of |other |exogenous |chemicals
1+1 |= |2 |- |CORRECT |ANSWER✔✔-Addition; |The |combined |effect |of |two |drugs |acting |via |the |
same |mechanism |is |equal |to |that |expected |by |simple |addition |of |their |individual |actions
Ex) |midazolam |+ |diazepam
1+1=3 |- |CORRECT |ANSWER✔✔-synergism; |The |combined |effect |of |two |drugs |is |greater |than |
the |sum |of |their |individuals |effects
Ex) |Midazolam |+ |Propofol
1+0=3 |- |CORRECT |ANSWER✔✔-potentiation; |The |enhancement |of |the |action |of |one |drug |by |a
|second |that |has |no |detectable |action |of |its |own. |
Ex) |Penicillin |+ |probenacid